Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Reviews: Molecular Basis of Heart Failure and its Treatments
The mechanism of contractile dysfunction in heart failure, focussing on SERCA2a function
Yoichiro KUSAKARIShuta HIRANOKenichi HONGOHiroyuki NAKAYAMAKinya OTSUSatoshi KURIHARA
Author information
JOURNAL FREE ACCESS

2004 Volume 123 Issue 2 Pages 87-93

Details
Abstract

Cytosolic Ca2+ is a key regulator of excitation-contraction coupling in myocardium. Myocardial contractile dysfunction in heart failure is characterized by a decrease in contraction and prolonged relaxation. These alterations are mainly due to changes in 1) intracellular Ca2+ transients (CaT), 2) Ca2+ sensitivity of the contractile elements, and/or 3) contractile proteins. It is useful to investigate the relationship between CaT and contraction for understanding of the mechanism of contractile dysfunction in heart failure. There are many reports regarding the alterations in CaT, Ca2+ sensitivity, and contractile proteins in heart failure. Changes in the activity of the sarcoplasmic Ca2+ pump protein, SERCA2a, may be involved in the altered contractility in heart failure. We generated cardiac-restricted overexpression of SERCA2a transgenic mice (TG) and non-transgenic littermates (NTG). To investigate the role of SERCA2a activity for ischemic heart, we used acidosis as a model of acute contractile dysfunction. During acidosis and recovery from acidosis, the peaks of CaT and tension in TG were significantly larger than those in NTG. These results suggest that an increase in the activity of SERCA2a could be beneficial to preserve contractility during acidosis and recovery. Thus, a disturbance of the intracellular Ca2+ homeostasis is one of the key factors for the contractile dysfunction in heart failure.

Content from these authors
© 2004 by The Japanese Pharmacological Society
Previous article Next article
feedback
Top